Publications

Wheeler MW, Dunson DB, Herring AH. 2017. Bayesian local extremum splines. Biometrika 104(4):939-52; doi: 10.1093/biomet/asx039. PMID: 29422695.

Stephenson CJ, Rossheim ME, Frankenfeld CL, Boncy J, Okech BO, von Fricken ME. 2017. Cross-sectional analysis of the association between bedtime and malaria exposure in the Ouest and Sud-Est Departments of Haiti. Acta Tropica 176(Dec):188–19; doi: 10.1016/j.actatropica.2017.08.011. PMID: 28818627.

Bare JL, Abramson MM, Barlow CA, Scott PK. Use of air dispersion modeling to estimate historical community exposure from manufacturers of asbestos-containing products. Abstract P.96, Society for Risk Analysis (SRA) Annual Meeting, Arlington, VA, December 2017.

Jensen IS, Wu E, Sacks N, Cyr P, Chung K. Budget impact analysis of CPX-351 in the treatment of patients with treatment-related acute myeloid leukemia (tAML) or AML with myelodysplasia-related changes (MRC) from a US payer perspective. Abstract 5615, 59th American Society of Hematology (ASH) Annual Meeting. Blood 130(Sup 1):5615; 10.1182/blood.V130.Suppl_1.5615.5615. Atlanta, GA, December 2017.

Lansita J, Mease KM, Qiu H, Yednock T, Sankaranarayanan S, Kramer S. 2017. Nonclinical development of ANX005: A humanized anti-Clq antibody for treatment of autoimmune and neurodegenerative diseases. Int J Toxicol 36(6)449-462; doi: 10.1177/1091581817740873. PMID: 29202623.

Schaefer HR, Ethridge S, Myers, JL. 2017. Development Support Document for Ethylene Dibromide. CAS Registry No.: 106-93-4. Final. November 29. Prepared for Texas Commission on Environmental Quality (TCEQ). Available from: https://www.tceq.texas.gov/downloads/toxicology/dsd/final/edb.pdf.

Williams A, Grulke C, Edwards J, McEachran A, Mansouri K, Baker N, Patlewicz G, Shah I, et al. 2017. The CompTox Chemistry Dashboard–A community data resource for environmental chemistry. J Cheminform 9(1):61; doi: 10.1186/s13321-017-0247-6. PMID: 29185060.

Liu J, Patlewicz G, Williams A, Thomas RS, Shah I. 2017. Predicting organ toxicity using in vitro bioactivity data and chemical structure. Chem Res Toxicol 30(11):2046-2059; doi: 10.1021/acs.chemrestox.7b00084. PMID: 28768096.

Butler L, Guzzie-Peck P, Hartke J, Bogdanffy M, Will Y, Diaz D, Mortimer-Cassen E,.., Greene N, et al. Revised draft EMA guidance on early clinical trials: Potential impacts and industry response. Abstract P204, American College of Toxicology 38th Annual Meeting. Int J Toxicol 37(1):75-76; doi: 10.1177/10915818177494. Palm Springs, CA, November 2017.

Thompson CM, Suh M, Proctor DM, Haws LC, Harris MA. 2017. Ten factors for considering the mode of action of Cr(VI)-induced gastrointestinal tumors in rodents. Mutat Res 823(Nov):45-57; doi: 10.1016/j.mrgentox.2017.08.004. PMID: 28985946.

Wheeler MW, Bailer AJ, Cole T, Park RM, Shao K. 2017. Bayesian quantile impairment threshold benchmark dose estimation for continuous endpoints. Risk Anal 37(11):2107-18; doi: 10.1111/risa.12762. PMID: 28555874.

Vincent MJ, Parker A, Maier A. 2017. Cleaning and asthma: A systematic review and approach for effective safety assessment. Regul Toxicol Pharmacol 90(Nov):231–243; doi: 10.1016/j.yrtph.2017.09.013. PMID: 28918194.

Wikoff D, Welsh BT, Henderson R, Brorby GP, Britt J,…, Harvey S, Urban J, Doepker C. 2017. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol 109(Pt1):585-648; doi: 10.1016/j.fct.2017.04.002. PMID: 28438661.

Vincent MJ, Bernstein JA, Basketter D, LaKind JS, Dotson GS, Maier A. 2017. Chemical-induced asthma and the role of clinical, toxicological, exposure and epidemiological research in regulatory and hazard characterization approaches. Regul Toxicol Pharmacol 90(Nov):126–132; doi: 10.1016/j.yrtph.2017.08.018. PMID: 28866265.

Wirbisky-Hershberger SE, Sanchez OF, Horzmann KA, Thanki D, Yuan C, Freeman JL. 2017. Atrazine exposure decreases the activity of DNMTs, global DNA methylation levels, and dnmt expression. Food Chem Toxicol 109(Pt 1):727–734; doi: 10.1016/j.fct.2017.08.041. PMID: 28859886.

Monticello TM, Jones TW, Dambach DM, Potter DM, Bolt MW, Liu M, Keller DA, Hart TK, et al. 2017. Current nonclinical testing paradigm enables safe entry to First-in-Human clinical trials: The IQ consortium nonclinical translational database. Toxicol Appl Pharmacol 334(Nov 1):100-109; doi: 10.1016/j.taap.2017.09.006. PMID: 28893587.

Pradeep P, Mansouri K, Patlewicz G, Judson RS. 2017. A systematic evaluation of analogs and automated read-across prediction of estrogenicity: A case study using hindered phenols. Comput Toxicol 4(Nov):22-30; doi: 10.1016/j.comtox.2017.09.001. PMID: 30057968.

Franzen A, Greene T, Van Landingham C, Gentry R. 2017. Toxicology of octamethylcyclotetrasiloxane (D4). Toxicol Lett 279(Suppl 1):2–22. doi: 10.1016/j.toxlet.2017.06.007. PMID: 28645863.

Gentry R, Franzen A, Van Landingham C, Greene T, Plotzke K. 2017. A global human health risk assessment for octamethylcyclotetrasiloxane (D4). Regul Toxicol Pharmacol 279(Sup 1):23-41; doi: 10.1016/j.toxlet.2017.05.019. PMID: 28522410.

Ruzin A, Levin-Sparenberg E, Pastula S, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Yu L, et al. Characterization of RSV strains among U.S. patients in the OUTSMART RSV program during 2015-16. Abstract and poster presentation, ID Week 2017, San Diego, CA, October 2017.